GLK-321

· Glaukos Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLK-321, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis [Phase 2]